Advances in the Prognostic Predication of Fetal Sacrococcygeal Teratoma

Wang Zhan,Tang Daxing
DOI: https://doi.org/10.3760/cma.j.issn.0253-3006.2016.09.016
2016-01-01
Abstract:Sacrococcygeal teratoma (SCT) is a common fetal and neonatal tumor in live births with an incidence of 1/40,000 to 1/35,000.And it has a male-to-female ratio of 1∶3 to 1∶4.The prognosis of SCT is generally fair after birth.However,the mortality of fetal SCT was reported at 16%to 63 % in the literature.Thus its prenatal diagnosis and prognostic indicators have become a hot focus of current researches.Here recent advances in its prognostic predication are reviewed.Various indicators such as tumor cystic proportion,tumor-fetal ratio (TFR),solid tumor volume divided by head volume (STV∶ HV),solid tumor volume index (STVI),tumor growth and cardiovascular profile score (CVPS) are discussed.In clinical practices,tumor cystic proportion and TFR are recommended.Or either STV∶ HV or STVI may be used.Tumor growth should be always monitored.CVPS may be monitored be to assess the extent of fetal heart failure to determine the timing of intervention.If high output heart failure occurs,fetal surgery should be performed in the first 28 weeks of pregnancy and therapeutic delivery should be considered after 28 weeks of pregnancy.Currently the prognosis of SCT fetus is still in an exploratory stage.Due to imperfect prenatal policies,more in-depth researches are warranted.
What problem does this paper attempt to address?